{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:27:25Z","timestamp":1787315245075,"version":"build-2736575974"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T00:00:00Z","timestamp":1668556800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>\n                    WHO has declared the outbreak of monkeypox as a public health emergency of international concern. In less than three months, monkeypox was detected in more than 30 000 people and spread to more than 80 countries around the world. It is believed that the immunity formed to smallpox vaccine can protect from monkeypox infection with high efficiency. The widespread use of Vaccinia virus has not been carried out since the 1980s, which raises the question of the level of residual immunity among the population and the identification of groups requiring priority vaccination. We conducted a cross-sectional serological study of remaining immunity among Moscow residents. To do this, a collection of blood serum samples of age group over 30 years old was formed, an\n                    <jats:italic>in-house<\/jats:italic>\n                    ELISA test system was developed, and a virus neutralization protocol was set up. Serum samples were examined for the presence of IgG antibodies against Vaccinia virus (\n                    <jats:italic>n<\/jats:italic>\n                    =2908), as well as for the ability to neutralize plaque formation with a Vaccinia virus MNIIVP-10 strain (\n                    <jats:italic>n<\/jats:italic>\n                    =299). The results indicate the presence of neutralizing antibody titer of 1\/20 or more in 33.3 to 53.2% of people older than 45 years. Among people 30-45 years old who probably have not been vaccinated, the proportion with virus neutralizing antibodies ranged from 3.2 to 6.7%. Despite the higher level of antibodies in age group older than 66 years, the proportion of positive samples in this group was slightly lower than in people aged 46-65 years. The results indicate the priority of vaccination in groups younger than 45, and possibly older than 66 years to ensure the protection of the population in case of spread of monkeypox among Moscow residents. The herd immunity level needed to stop the circulation of the virus should be at least 50.25 \u2013 65.28%.\n                  <\/jats:p>","DOI":"10.3389\/fimmu.2022.1023164","type":"journal-article","created":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T02:41:49Z","timestamp":1668566509000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Estimation of anti-orthopoxvirus immunity in Moscow residents and potential risks of spreading Monkeypox virus"],"prefix":"10.3389","volume":"13","author":[{"given":"Vladimir A.","family":"Gushchin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darya A.","family":"Ogarkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inna V.","family":"Dolzhikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga V.","family":"Zubkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor V.","family":"Grigoriev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrei A.","family":"Pochtovyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna A.","family":"Iliukhina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana A.","family":"Ozharovskaia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadezhda A.","family":"Kuznetsova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daria D.","family":"Kustova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Artem Y.","family":"Shelkov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis I.","family":"Zrelkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alina S.","family":"Odintsova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daria M.","family":"Grousova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladislav Y.","family":"Kan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sona A.","family":"Davtyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrei E.","family":"Siniavin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizaveta D.","family":"Belyaeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrei G.","family":"Botikov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arina A.","family":"Bessonova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyudmila A.","family":"Vasilchenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daria V.","family":"Vasina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis A.","family":"Kleymenov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Egor A.","family":"Slutskiy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Artem P.","family":"Tkachuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga A.","family":"Burgasova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetlana Y.","family":"Loginova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evgeny V.","family":"Rozhdestvensky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmitry V.","family":"Shcheblyakov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander N.","family":"Tsibin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrey G.","family":"Komarov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir I.","family":"Zlobin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergei V.","family":"Borisevich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris S.","family":"Naroditsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis Y.","family":"Logunov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander L.","family":"Gintsburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,11,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3923\/ajava.2010.77.92","article-title":"Viral zoonosis: a comprehensive review","volume":"5","author":"Venkatesan","year":"2010","journal-title":"J Vet Anim Adv"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s13337-012-0068-18","article-title":"Emergence and reemergence of vaccinia-like viruses: Global scenario and perspectives","volume":"23","author":"Singh","year":"2012","journal-title":"Indian J Virol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/17.3.643","article-title":"The transmission potential of monkeypox virus in human populations","volume":"17","author":"Fine","year":"1988","journal-title":"Int J Epidemiol."},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0010141","article-title":"The changing epidemiology of human monkeypox-a potential threat? a systematic review","volume":"16","author":"Bunge","year":"2022","journal-title":"PloS Negl Trop Dis"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23147866","article-title":"Monkeypox: A new threat","volume":"23","author":"Kmiec","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3201\/eid2704.203569","article-title":"Reemergence of human monkeypox and declining population immunity in the context of urbanization, Nigeria, 2017-2020","volume":"27","author":"Nguyen","year":"2021","journal-title":"Emerg Infect Dis"},{"key":"B7","doi-asserted-by":"publisher","first-page":"69","DOI":"10.35825\/2587-5728-2020-4-1-66-85","article-title":"Monkeypox: features of spread after cancellation of mandatory pox immunization","author":"Borisevich","year":"2012","journal-title":"Zh Mikrobiol Epidemiol Immunobiol."},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1086\/498115","article-title":"Clinical characteristics of human monkeypox, and risk factors for severe disease","volume":"41","author":"Huhn","year":"2005","journal-title":"Clin Infect Dis"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3201\/eid2604.191164","article-title":"Human-to-human transmission of monkeypox virus, united kingdom, October 2018","volume":"26","author":"Vaughan","year":"2020","journal-title":"Emerg Infect Dis"},{"key":"B10","article-title":"Confirmed cases of monkeypox since April 29, 2022","year":"2022"},{"key":"B11","unstructured":"First case of monkeypox infection detected in Russia2022"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.1972.21.214","article-title":"A prospective study of serum antibody and protection against smallpox","volume":"21","author":"Mack","year":"1972","journal-title":"Am J Trop Med Hyg"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1093\/milmed\/usz181","article-title":"Evidence for residual immunity to smallpox after vaccination and implications for re-emergence","volume":"184","author":"Kunasekaran","year":"2019","journal-title":"Mil Med"},{"key":"B14","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s12985-016-0575-6","article-title":"Seroprevalence of orthopoxvirus in rural Brazil: insights into anti-OPV immunity status and its implications for emergent zoonotic OPV","volume":"13","author":"Costa","year":"2016","journal-title":"Virol J"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0033392","article-title":"A novel high-throughput vaccinia virus neutralization assay and preexisting immunity in populations from different geographic regions in China","volume":"7","author":"Liu","year":"2012","journal-title":"PloS One"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1385\/1-59259-789-0:243","article-title":"Monitoring of human immunological responses to vaccinia virus","volume":"269","author":"Harrop","year":"2004","journal-title":"Methods Mol Biol"},{"key":"B17","unstructured":"2022"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1101\/2022.07.26.22278042","article-title":"Reproduction number of monkeypox in the early stage of the 2022 multi-country outbreak","author":"Du","year":"2022","journal-title":"MedRxiv [Preprint]"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)01106-0","article-title":"Monkeypox genomic surveillance will challenge lessons learned from SARS-CoV-2","volume":"400","author":"Pfaff","year":"2022","journal-title":"Lancet"},{"key":"B20","unstructured":"IsidroJ\n            BorgesV\n            PintoM\n            FerreiraR\n          Multi-country outbreak of monkeypox virus: genetic divergence and first signs of microevolution. virological \u2013 monkeypox genome reports2022"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.37069","article-title":"COVID-19 outcomes among persons living with or without diagnosed HIV infection in new York state","volume":"4","author":"Tesoriero","year":"2021","journal-title":"JAMA Netw Open"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3201\/eid2710.211461","article-title":"SARS-CoV-2 neutralization resistance mutations in patient with HIV\/AIDS, California, USA","volume":"27","author":"Hoffman","year":"2021","journal-title":"Emerg Infect Dis"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.3786","article-title":"COVID-19: Prolonged viral shedding in an HIV patient with literature review of risk factors for prolonged viral shedding and its implications for isolation strategies","volume":"9","author":"Yousaf","year":"2021","journal-title":"Clin Case Rep"},{"key":"B24","unstructured":"Products2022"},{"key":"B25","doi-asserted-by":"publisher","first-page":"66","DOI":"10.35825\/2587-5728-2020-4-1-66-85","article-title":"Evolution of means and principles of smallpox vaccination","volume":"4","author":"Borisevich","year":"2020","journal-title":"J NBC Prot Corps"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.942796","article-title":"Immunosenescence, aging and successful aging","volume":"13","author":"Wang","year":"2022","journal-title":"Front Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.945016","article-title":"Immunosenescence in atherosclerosis: A role for chronic viral infections","volume":"13","author":"Ghamar Talepoor","year":"2022","journal-title":"Front Immunol"},{"key":"B28","unstructured":"Vidal: a reference book of preparations and medicines. smallpox vaccine live (smallpox vaccine) instructions for use: indications, contraindications, side effects \u2013 description of lyophilizate for preparing a solution for intradermal administration (42889)2021"},{"key":"B29","unstructured":"Vidal: a reference book of preparations and medicines. TEOVac instructions for use: indications, contraindications, side effects - description of TEOVac tab. cover shell 1 dose: 10, 20, 30, 50, 60, 75, 100, 125, 150, 200, 250, 270, 275, 300, 360, 450, 600 (35261)2019"},{"key":"B30","unstructured":"State register of medicines. OspaVir\u00ae inactivated smallpox vaccine2021"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/nm917","article-title":"Duration of antiviral immunity after smallpox vaccination","volume":"9","author":"Hammarlund","year":"2003","journal-title":"Nat Med"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2008.08.019","article-title":"Immunity from smallpox vaccine persists for decades: A longitudinal study","volume":"121","author":"Taub","year":"2008","journal-title":"Am J Med"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1128\/CDLI.12.4.520-524.2005","article-title":"Persisting humoral antiviral immunity within the Japanese population after the discontinuation in 1976 of routine smallpox vaccinations","volume":"12","author":"Hatakeyama","year":"2005","journal-title":"Clin Diagn Lab Immunol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/414748a","article-title":"Transmission potential of smallpox in contemporary populations","volume":"414","author":"Gani","year":"2001","journal-title":"Nature"},{"key":"B35","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.cell.2016.09.049","article-title":"Cross-neutralizing and protective human antibody specificities to poxvirus infections","volume":"167","author":"Gilchuk","year":"2016","journal-title":"Cell."},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/s0042-6822(02)00038-7","article-title":"Four-gene-combination DNA vaccine protects mice against a lethal vaccinia virus challenge and elicits appropriate antibody responses in nonhuman primates","volume":"306","author":"Hooper","year":"2003","journal-title":"Virology."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.1023164\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T02:41:54Z","timestamp":1668566514000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.1023164\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,16]]},"references-count":36,"alternative-id":["10.3389\/fimmu.2022.1023164"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.1023164","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,16]]},"article-number":"1023164"}}